The influence of anaesthetic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy

World Journal of Biological Psychiatry

Volumn 11, Issue 2 PART 2, 2010, Pages 447-456

  Eser, Daniela ^a   Nothdurfter, Caroline ^a   Suchüle, Cornelius ^a   Damm, Julia ^a   Steng, Yvonne ^a   Möller, Hans Jürgen ^a   Rupprecht, Rainer ^a   Baghai, Thomas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Anaesthetics; Clinical effectiveness; Concomitant medication; Electroconvulsive therapy; Safety

Indexed keywords

ANESTHETIC AGENT; ATRACURIUM; ETOMIDATE; METHOHEXITAL; PROPOFOL; PYRIDOSTIGMINE; SUXAMETHONIUM; THIOPENTAL;

ADULT; AGED; ARTICLE; ASYSTOLE; BIPOLAR DEPRESSION; COGNITIVE DEFECT; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; ELECTROPHYSIOLOGY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HEART VENTRICLE EXTRASYSTOLE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PARANOID SCHIZOPHRENIA; PATIENT SAFETY; PERSONALITY DISORDER; SCHIZOAFFECTIVE PSYCHOSIS; SEIZURE; SINUS TACHYCARDIA; TREATMENT OUTCOME;

AGED; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; ETOMIDATE; FEMALE; HUMANS; MALE; METHOHEXITAL; MIDDLE AGED; PROPOFOL; RETROSPECTIVE STUDIES; SEIZURES; THIOPENTAL;

EID: 77950841061     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970902960897     Document Type: Article

References (43)

1. Abrams R. 2002. Stimulus titration and ECT dosing. J ECT 18: 3-9.
2. AgelinkMW, Dammers S,Malessa R, Leonhardt M, Zitzelsberger A, Ullrich H, et al. 1998. Benefits and risks of electroconvulsive therapy (ECG) in elderly patients with cardiovascular risk factors. Nervenarzt 69:70-75.
3. Avramov MN, Husain MM, White PF. 1995. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 81:596-602.
4. Baghai TC, Marcuse A, Brosch M, Schule C, Eser D, Nothdurfter C, et al. 2006. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 7:82-90. (Pubitemid 43738905)
5. d'Elia G. 1970. Unilateral electroconvulsive therapy. Acta Psychiatr Scand Suppl 215:1-98.
6. d'Elia G, Raotma H. 1975. Is unilateral ECT less effective than bilateral ECT? Br J Psychiatry 126:83-89.
7. DeBattista C, Mueller K. 2001. Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder? J ECT 17:91-98.
8. Dell'Osso B, Altamura AC, Allen A, Hollander E. 2005. Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions. CNS Spectr 10:966-979.
9. Dew RE, Kimball JN, Rosenquist PB, McCall WV. 2005. Seizure length and clinical outcome in electroconvulsive therapy using methohexital or thiopental. J ECT 21:16-18.
10. Ding Z, White PF. 2002. Anesthesia for electroconvulsive therapy. Anesth Analg 94:1351-1364.
11. Dwyer R, McCaughey W, Lavery J, McCarthy G, Dundee JW. 1988. Comparison of propofol and methohexitone as anaesthetic agents for electroconvulsive therapy. Anaesthesia 43: 459-462.
12. ECT review group. 2003. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and metaanalysis. Lancet 361:799-808.
13. Fear CF, Littlejohns CS, Rouse E, McQuail P. 1994. Propofol anaesthesia in electroconvulsive therapy. Reduced seizure duration may not be relevant. Br J Psychiatry 165:506-509.
14. Frey R, Heiden A, Scharfetter J, Schreinzer D, Blasbichler T, Tauscher J, et al. 2001. Inverse relation between stimulus intensity and seizure duration: implications for ECT procedure. J ECT 17:102-108.
15. Gazdag G, Kocsis N, Tolna J, Ivanyi Z. 2004. Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. J ECT 20:225-229.
16. Geretsegger C, Rochowanski E, Kartnig C, Unterrainer AF. 1998. Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizure-quality measures and vital signs. J ECT 14:28-35.
17. Geretsegger C, Nickel M, Judendorfer B, Rochowanski E, Novak E, Aichhorn W. 2007. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, doubleblind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT 23:239-243.
18. Gitlin M. 2006. Treatment-resistant bipolar disorder. Mol Psychiatry 11:227-240.
19. Grati L, Louzi M, Nasr K, Zili N, Mansalli L, Mechri A, et al. 2005. Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy. Presse Med 34: 282-284.
20. Greenblatt M, Grosser GH, Wechsler HA 1964. Differential response of hospitalized depressed patients in somatic therapy. Am J Psychiatry 935-943.
21. Grunze H. 2005. Reevaluating therapies for bipolar depression. J Clin Psychiatry 66(Suppl 5):17-25.
22. Malsch E, Gratz I, Mani S, Backup C, Levy S, Allen E. 1994. Efficacy of electroconvulsive therapy after propofol and methohexital anesthesia. Convuls Ther 10:212-219.
23. Martensson B, Bartfai A, Hallen B, Hellstrom C, Junthe T, Olander M. 1994. A comparison of propofol and methohexital as anesthetic agents for ECT: effects on seizure duration, therapeutic outcome, and memory. Biol Psychiatry 35: 179-189.
24. Martin BA, Cooper RM, Parikh SV. 1998. Propofol anesthesia, seizure duration, and ECT: a case report and literature review. J ECT 14:99-108.
25. Matters RM, Beckett WG, Kirkby KC, King TE. 1995. Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. Br J Anaesth 75:297-300.
26. Mokriski BK, Nagle SE, Papuchis GC, Cohen SM, Waxman GJ. 1992. Electroconvulsive therapy-induced cardiac arrhythmias during anesthesia with methohexital, thiamylal, or thiopental sodium. J Clin Anesth. 4:208-212.
27. National Institute of Mental Health. 1976. 028 CGI. Clinical Global Impressions. In: Guy W, Bonato RRManual for the EDCEU Assessment Battery. 2nd revision Chevy Chase, MD: National Institute of Mental Health. p 12-1-12-6.
28. Newton-Howes G, Tyrer P, Johnson T. 2006. Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry 188:13-20.
29. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. 1993. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry 34:321-330.
30. Nothdurfter C, Eser D, Schule C, Zwanzger P, Marcuse A, Noack I, et al. 2006. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 7:162-170. (Pubitemid 44132542)
31. Prudic J, Sackeim HA, Devanand DP. 1990. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 31:287-296.
32. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, et al. 1996. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 153:985-992.
33. Rice EH, Sombrotto LB, Markowitz JC, Leon AC. 1994. Cardiovascular morbidity in high-risk patients during ECT. Am J Psychiatry 151:1637-1641.
34. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, et al. 2000. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 57:425-434.
35. Sartorius A, HewerW. 2007. Safe performance of ECT in severely ill patients: A retrospective study. Eur J Psychiat 21:237-247.
36. Stromgren LS, Dahl J, Fjeldborg N, Thomsen A. 1980. Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines. Acta Psychiatr Scand 62:158-165.
37. Suppes T,Webb A, Carmody T, Gordon E, Gutierrez-Esteinou R, Hudson JI, et al. 1996. Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affect Disord 41: 55-58.
38. Swartz CM, Larson G. 1986. Generalization of the effects of unilateral and bilateral ECT. Am J Psychiatry 143:1040-1041.
39. Tharyan P, Adams CE. 2005. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev: CD000076.
40. Weiner RD, Weaver LA Jr, Sackeim HA. 1988. Reporting of technical parameters in ECT publications: Recommendations for authors. Convuls Ther 4:88-91.
41. Weiner RD, Coffey CE, Krystal AD. 1991. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am 14:845-869.
42. World Health Organization. 1992. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization.
43. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA. 1993. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 150:904-909.